Literature DB >> 25868786

Endoscopic bariatric procedures.

Jacques Deviere1.   

Abstract

OPINION STATEMENT: Obesity is a pandemy which affects 600 million adults worldwide. Surgery is the only therapy which has been shown effective on the long term. Transoral surgery (or endotherapy) is particularly attractive in this group of patients and has the potential for offering a less invasive alternative. If the only treatment currently available in routine is balloon implantation, which is effective at short term but unfortunately associated with weight regain after removal in the majority of the cases, other techniques currently under development or clinical investigations might fine their place in future treatment armamentarium. They include restrictive procedures, involving plicature formation or tissue apposition in order to reduce the volume of the stomach, decrease its compliance, and favor an early satiety. Other techniques focus on malabsorption, either by bypassing the contact of food with the jejunum (a feature which also improves type 2 diabetes) or by emptying the stomach after food intake. Several techniques also allow performing gastrojejunal anastomoses. These could be particularly useful in designing hybrid procedures combining laparoscopic and transoral approach resulting in less invasive surgical procedures. Even if, currently, none of these techniques can be recommended outside clinical protocols, it becomes more and more obvious that some of them will find their place in the near future.

Entities:  

Year:  2015        PMID: 25868786     DOI: 10.1007/s11938-015-0054-y

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  40 in total

1.  Short-term safety and efficacy of the Trans-oral Endoscopic Restrictive Implant System for the treatment of obesity.

Authors:  Koen de Jong; Elisabeth M H Mathus-Vliegen; Elisabeth A M L Veldhuyzen; Jan H Eshuis; Paul Fockens
Journal:  Gastrointest Endosc       Date:  2010-06-11       Impact factor: 9.427

2.  The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.

Authors:  Parviez Koehestanie; Charlotte de Jonge; Frits J Berends; Ignace M Janssen; Nicole D Bouvy; Jan Willem M Greve
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

3.  Is the gut the "sweet spot" for the treatment of diabetes?

Authors:  Francesco Rubino; Stephanie A Amiel
Journal:  Diabetes       Date:  2014-07       Impact factor: 9.461

Review 4.  The treatment and prevention of obesity: a systematic review of the literature.

Authors:  A M Glenny; S O'Meara; A Melville; T A Sheldon; C Wilson
Journal:  Int J Obes Relat Metab Disord       Date:  1997-09

5.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

6.  Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study.

Authors:  C Moreno; J Closset; S Dugardeyn; M Baréa; A Mehdi; L Collignon; M Zalcman; M Baurain; O Le Moine; J Devière
Journal:  Endoscopy       Date:  2008-05       Impact factor: 10.093

7.  Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients.

Authors:  Roberto Fogel; Juana De Fogel; Ydaly Bonilla; Rafael De La Fuente
Journal:  Gastrointest Endosc       Date:  2008-03-19       Impact factor: 9.427

8.  An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity.

Authors:  Vincent Aguirre; Nicholas Stylopoulos; Ronit Grinbaum; Lee M Kaplan
Journal:  Obesity (Silver Spring)       Date:  2008-10-30       Impact factor: 5.002

Review 9.  Gut hormones and appetite control.

Authors:  A M Wren; S R Bloom
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

10.  Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study.

Authors:  J Devière; G Ojeda Valdes; L Cuevas Herrera; J Closset; O Le Moine; P Eisendrath; C Moreno; S Dugardeyn; M Barea; R de la Torre; S Edmundowicz; S Scott
Journal:  Surg Endosc       Date:  2007-11-01       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.